LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • May 8th, 2019 • Exicure, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AND DEVELOPMENT AGREEMENT (the “Agreement”) is dated as of February 17, 2019 (the “Effective Date”) by and between EXICURE, INC., a Delaware corporation with an address of 8045 Lamon Avenue, Suite 410, Skokie, IL 60077 (“Exicure”), and DERMELIX, LLC, d/b/a Dermelix Biotherapeutics, a Delaware corporation with an address of 275 7th Avenue, Suite 710, New York, NY 10011 (“Dermelix”).
